India’s TB Labs Face a Capacity Gap
Researchers identified gaps in molecular diagnostics, drug susceptibility testing, and treatment monitoring
Clinical Scorecard: India’s TB Labs Face a Capacity Gap
At a Glance
| Category | Detail |
|---|
| Condition | Tuberculosis (TB) |
| Key Mechanisms | Culture and drug susceptibility testing (CDST) to confirm TB and identify resistance. |
| Target Population | Individuals at risk of or diagnosed with tuberculosis in India. |
| Care Setting | Public health facilities across India. |
Key Highlights
- India has 97 CDST laboratories but requires 283, indicating a 62% shortfall.
- Only 5% of primary health centers offer the complete set of TB tests recommended.
- Acid-fast bacilli smear microscopy is available in 78% of recommended facilities.
- Access to laboratory tests is uneven, affecting TB treatment and management.
- Strengthening diagnostic access could help achieve National TB Elimination Program goals.
Guideline-Based Recommendations
Diagnosis
- Implement comprehensive TB testing at all levels of care.
Management
- Expand CDST capacity to improve identification of drug-resistant TB.
Monitoring & Follow-up
- Regular assessment of TB treatment units and diagnostic laboratories.
Risks
- Limited CDST capacity may delay detection of drug-resistant Mycobacterium tuberculosis.
Patient & Prescribing Data
Individuals diagnosed with TB or at risk of TB in India.
Access to timely and accurate diagnostic tests is critical for effective treatment.
Clinical Best Practices
- Strengthen diagnostic access at peripheral health facilities.
- Ensure availability of recommended TB tests at all levels of care.
Related Resources & Content
